Dergiler / Neurological sciences and neurophysiology (Online) / 2021 / Cilt: 38 - Sayı: 2

Data Mining Analysis of Demographic and Clinical Factors in Turkish Amyotrophic Lateral Sclerosis Patients

Sayfa
111–119
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The results also showed that there was no relationship between demographic and clinical features such as gender, occupation, age group, and concomitant disease between groups or within groups.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that affects nerve cells in the brain and spinal cord, controlling voluntary muscle movement.
📊
Temel Bulgular & Veri:Methods: In the study, data belonging to 235 patients diagnosed with ALS and a control group of 117 people consisting of relatives of ALS patients were used.
💡
Sonuç & Katkı:The results also showed that there was no relationship between demographic and clinical features such as gender, occupation, age group, and concomitant disease between groups or within groups.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that affects nerve cells in the brain and spinal cord, controlling voluntary muscle movement. Data mining is a discipline that provides meaningful conclusions from databases or implicit data. In this study, we examine the relationship between the clinical and demographic characteristics of ALS patients and a control group, using data mining techniques. Methods: In the study, data belonging to 235 patients diagnosed with ALS and a control group of 117 people consisting of relatives of ALS patients were used. The dataset contains 121 features that include clinical and demographic information for each patient. The patient group and the control group were examined together and separately to examine the relationship between the features. In the study the data mining methods of classification and clustering were used on R and WEKA software packages. Results: There were no significant differences between ALS patients and the control group in terms of environmental factors such as location, gender, smoking, exercise status, and clinical factors such as genetics, ALS involvement, course of the disease, disease in the family. The results also showed that there was no relationship between demographic and clinical features such as gender, occupation, age group, and concomitant disease between groups or within groups.

🔖

Bu Makaleye Atıf Yap

UYSAL, H., BİLGE, U., GÜLAY, N. Ç., ALİYEVA, P. (2022). Data Mining Analysis of Demographic and Clinical Factors in Turkish Amyotrophic Lateral Sclerosis Patients. Neurological sciences and neurophysiology (Online), Cilt: 38 - Sayı: 2, 111–119. https://ajindex.com/articles/584315

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Eisen A, Krieger C. Amyotrophic Lateral Sclerosis: A Synthesis of Research and Clinical Practice. New York: Cambridge University Press; 1998
  2. National Institute of Neurological Disorders and Stroke. Office of Communications and Public Liaison Amyotrophic Lateral Sclerosis (ALS) Fact Sheet. Available from: https://www.ninds. nih.gov. [Last accessed on 2020 May 01]
  3. Majoor‑Krakauer D, Willem PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 2002;63:83‑101
  4. Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000‑2015: Prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:522‑7
  5. Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 2019;90:395‑403
  6. Turgut N, Varol SaraÇoglu G, Kat S, Balci K, GÜldiken B, Birgili O, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006‑2010. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:100‑6
  7. Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D. Amyotrophic lateral sclerosis in Bejing: Epidemiologic features and prognosis from 2010 to 2015. Brain Behav 2018;8:Eo1131
  8. Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G, et al. Changing epidemiology of motor neurone disease in Scotland. J Neurol 2019;266:817‑25
  9. Rose L, McCim D, Lease D, Nonoyama M, Tandon A, Bai YQ, et al. Trends in incidence, prevalence, and mortality of neuromusculer disease in Ontario, Canada: A population‑based retrospective cohort study (2003‑3014). PLoS One 2019;14:E0210574
  10. Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr Opin Neurol 2019;32:771‑6
  11. Uysal H, Taghiyeva P, Türkay M, Köse F, Aktekin M. Amyotrophic lateral sclerosis in Antalya, Turkey. A prospective study, 2016‑2018. Amyotroph Lateral Scler Frontotemporal Degener 2020:1‑7
  12. Hastings MH, Goedert M. Circadian clocks and neurodegenerative diseases: Time to aggregate? Curr Opin Neurobiol 2013;23:880‑7
  13. Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review. Amyotroph Lateral Scler 2009;10:302‑9
  14. Hamidou B, Couratier P, Besançon C, Nicol M, Preux PM, Marin B. Epidemiological evidence that phy